COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,889 Articles (22,568 medRxiv, 8,321 bioRxiv)

Most recent first Previous |  Page 1059: Articles 10581-10590  | Next

Safety and immunogenicity of the third booster dose with inactivated, viral vector, and mRNA COVID-19 vaccines in fully immunized healthy adults with inactivated vaccine
Kanokudom, S., Assawakosri, S., Suntronwong, N., Auphimai, C., Nilyanimit, P., Vichaiwattana, P., Thongmee, T., Yorsaeng, R., Srimuan, D., Thatsanatorn, T., Klinfueng, S., Sudhinaraset, N., Wanlapakorn, N., Honsawek, S., Poovorawan, Y.
10.1101/2021.12.03.21267281 — Posted: 2021-12-05
Mucosal memory T cells in breastmilk are modulated by SARS-CoV-2 mRNA vaccination
Armistead, B., Jiang, Y., Carlson, M., Ford, E. S., Jani, S., Houck, J., Wu, X., Pecor, T., Kachikis, A., Yeung, W., Nguyen, T., Minkah, N., Larsen, S. E., Coler, R. N., Koelle, D. M., Harrington, W. E.
10.1101/2021.12.03.21267036 — Posted: 2021-12-05
Ad26.COV2.S or BNT162b2 Boosting of BNT162b2 Vaccinated Individuals
Tan, C. S., Collier, A.-r., Liu, J., Yu, J., Wan, H., McMahan, K., He, X., Jacob-Dolan, C., Chandrashekar, A., Sellers, D., Stephenson, K., Vidal, S., Jaegle, K., Curran, J., Rowe, M., Hemod, R., Bermudez Rivera, L., Anioke, T., Barrett, J., Chung, B., Gardner, S., Gebre, M., Lifton, M., Powers, O., VanWyk, H., Wu, C., Barouch, D.
10.1101/2021.12.02.21267198 — Posted: 2021-12-05 Discussion: Onsite
Comparison of different sequencing techniques with multiplex real-time PCR for detection to identify SARS-CoV-2 variants of concern
Ranasinghe, D., Jayadas, T., Jayathilaka, D., Jeewandara, C., Dissanayaka, O., Guruge, D., Ariyaratne, D., Gunasinghe, D., Gomes, L., Wijesinghe, A., Wijayamuni, R., Malavige, G. N.
10.1101/2021.12.05.21267303 — Posted: 2021-12-05
S glycoprotein diversity of the Omicron Variant
Sarkar, R., Lo, M., Saha, R., Dutta, S., Chawla-Sarkar, M.
10.1101/2021.12.04.21267284 — Posted: 2021-12-05
Longitudinal study of DNA methylation and epigenetic clocks prior to and following test-confirmed COVID-19 and mRNA vaccination
Pang, A. P., Higgins-Chen, A. T., Comite, F., Raica, I., Arboleda, C., Mendez, T., Schotsaert, M., Dwaraka, V., Smith, R., Levine, M. E., Ndhlovu, L. C., Corley, M. J.
10.1101/2021.12.01.21266670 — Posted: 2021-12-05
Evaluating the policy of closing bars and restaurants in Cataluya and its effects on mobility and COVID19 incidence
SMITH, M., Ponce de Leon, M., Valencia, A.
10.1101/2021.12.03.21267172 — Posted: 2021-12-05
A mixed-methods study of risk factors and experiences of healthcare workers tested for the novel coronavirus in Canada
Okpani, A. I., Barker, S., Lockhart, K., Grant, J. M., Delgado-Ron, J. A., Zungu, M., Naicker, N., Ehrlich, R., Yassi, A.
10.1101/2021.12.04.21267231 — Posted: 2021-12-05
Brain Injury in COVID-19 is Associated with Autoinflammation and Autoimmunity
Needham, E. J., Ren, A. L., Digby, R. J., Outtrim, J. G., Chatfield, D. A., Newcombe, V. F., Doffinger, R., Barcenas-Morales, G., Fonseca, C., Taussig, M. J., Burnstein, R. M., Dunai, C., Sithole, N., Ashton, N. J., Zetterberg, H., Gisslen, M., Arvid, E., Marklund, E., Griffiths, M. J., Cavanagh, J., Breen, G., Irani, S. R., Elmer, A., Kingston, N., Bradley, J. R., Taams, L. S., michael, B. D., Bullmore, E. T., Smith, K. G., Lyons, P. A., Coles, A. J., Menon, D. K., Cambridge NeuroCOVID Group, , NIHR Cambridge Covid BioResource, , NIHR Cambridge Clinical Research Facility
10.1101/2021.12.03.21266112 — Posted: 2021-12-05
Long Term Humoral Immunity Decline in Hemodialysis Patients Following SARS-CoV-2 Vaccination
Goggins, E., Sharma, B., Ma, J. Z., Gautam, J., Bowman, B.
10.1101/2021.12.01.21265957 — Posted: 2021-12-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).